BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31705772)

  • 21. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
    Busch K; Keller T; Fuchs U; Yeh RF; Harbott J; Klose I; Wiemels J; Novosel A; Reiter A; Borkhardt A
    Leukemia; 2007 Aug; 21(8):1739-51. PubMed ID: 17541401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transformation of a low-grade follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing Terminal deoxynucleotidyl Transferase: a case report.
    Bouroumeau A; Kaphan E; Legrand C; Raskovalova T; Szymanski G; Vettier C; Lefebvre C; Jacob MC; McLeer A; Peuchmaur M; Gressin R; Sartelet H
    J Med Case Rep; 2020 Jul; 14(1):117. PubMed ID: 32713346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.
    McClure RF; Remstein ED; Macon WR; Dewald GW; Habermann TM; Hoering A; Kurtin PJ
    Am J Surg Pathol; 2005 Dec; 29(12):1652-60. PubMed ID: 16327438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MYC rearrangement involving a novel non-immunoglobulin chromosomal locus in precursor B-cell acute lymphoblastic leukemia.
    Seo JY; Lee SH; Kim HJ; Yoo KH; Koo HH; Cho YG; Choi SI; Kim SH
    Ann Lab Med; 2012 Jul; 32(4):289-93. PubMed ID: 22779071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mature B-cell acute lymphoblastic leukemia with t(9;11) translocation: a distinct subset of B-cell acute lymphoblastic leukemia.
    Tsao L; Draoua HY; Osunkwo I; Nandula SV; Murty VV; Mansukhani M; Bhagat G; Alobeid B
    Mod Pathol; 2004 Jul; 17(7):832-9. PubMed ID: 15098014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge.
    Khanlari M; Medeiros LJ; Lin P; Xu J; You MJ; Tang G; Yin CC; Wang W; Qiu L; Miranda RN; Bueso-Ramos CE; Li S
    Mod Pathol; 2022 Mar; 35(3):419-426. PubMed ID: 34608246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression.
    Valera A; Epistolio S; Colomo L; Riva A; Balagué O; Dlouhy I; Tzankov A; Bühler M; Haralambieva E; Campo E; Soldini D; Mazzucchelli L; Martin V
    Mod Pathol; 2016 Aug; 29(8):844-53. PubMed ID: 27125356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype.
    Truffinet V; Pinaud E; Cogné N; Petit B; Guglielmi L; Cogné M; Denizot Y
    J Immunol; 2007 Nov; 179(9):6033-42. PubMed ID: 17947677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS.
    Hüttl KS; Staiger AM; Richter J; Ott MM; Kalmbach S; Klapper W; Biesdorf AS; Trümper L; Rosenwald A; Ziepert M; Horn H; Ott G
    Virchows Arch; 2021 Sep; 479(3):575-583. PubMed ID: 33655392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc.
    Merchant S; Schlette E; Sanger W; Lai R; Medeiros LJ
    Arch Pathol Lab Med; 2003 Mar; 127(3):305-9. PubMed ID: 12653573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents.
    De Souza MT; Hassan R; Liehr T; Marques-Salles TJ; Boulhosa AM; Abdelhay E; Ribeiro RC; Silva ML
    Pediatr Blood Cancer; 2014 Aug; 61(8):1422-6. PubMed ID: 24668946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature.
    Woroniecka R; Rymkiewicz G; Szafron LM; Blachnio K; Szafron LA; Bystydzienski Z; Pienkowska-Grela B; Borkowska K; Rygier J; Kotyl A; Malawska N; Wojtkowska K; Parada J; Borysiuk A; Murcia Pienkowski V; Rydzanicz M; Grygalewicz B
    PLoS One; 2022; 17(2):e0263980. PubMed ID: 35167621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
    Aukema SM; Croci GA; Bens S; Oehl-Huber K; Wagener R; Ott G; Rosenwald A; Kluin PM; van den Berg E; Bosga-Bouwer AG; Hoogendoorn M; Hoster E; Bittmann I; Nagel I; Murga Penas EM; Kreuz M; Bausinger J; Belder W; Oschlies I; Dyer MJS; Jayne S; Siebert R; Klapper W
    Virchows Arch; 2021 Jul; 479(1):133-145. PubMed ID: 33528622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
    Bischin AM; Dorer R; Aboulafia DM
    Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double-hit high-grade B-cell lymphoma, and single-hit MYC-rearranged diffuse large B-cell lymphoma.
    Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Liapis K; Gortzolidis G; Kostopoulos IV; Marinakis T; Paterakis G
    Cytometry B Clin Cytom; 2020 Sep; 98(5):412-420. PubMed ID: 32497402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additional flow cytometric studies for differential diagnosis between Burkitt lymphoma/leukemia and B-cell precursor acute lymphoblastic leukemia.
    Demina I; Voropayev A; Semchenkova A; Zerkalenkova E; Olshanskaya Y; Samochatova E; Novichkova G; Miakova N; Maschan A; Popov A
    Leuk Res; 2021 Jan; 100():106491. PubMed ID: 33340851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
    Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
    Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.
    Beishuizen A; Verhoeven MA; van Wering ER; Hählen K; Hooijkaas H; van Dongen JJ
    Blood; 1994 Apr; 83(8):2238-47. PubMed ID: 8161789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precursor B-cell acute lymphoblastic leukaemia with FAB L3 (i.e., Burkitt's leukaemia/lymphoma) morphology and co-expression of monoclonal surface light chains and Tdt: report of a unique case and review of the literature.
    Higa B; Alkan S; Barton K; Velankar M
    Pathology; 2009; 41(5):495-8. PubMed ID: 19900092
    [No Abstract]   [Full Text] [Related]  

  • 40. Elucidating a false-negative
    Peterson JF; Pitel BA; Smoley SA; Vasmatzis G; Smadbeck JB; Greipp PT; Ketterling RP; Macon WR; Baughn LB
    Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.